Exchange Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,139
| Closed | -$4.67M | – | 195 |
|
|
2024
Q2 | $4.67M | Sell |
20,139
-209
| -1% | -$45.4K | 0.76% | 40 |
|
|
2024
Q1 | $4.39M | Buy |
20,348
+50
| +0.2% | +$11.7K | 0.71% | 44 |
|
|
2023
Q4 | $5.25M | Buy |
20,298
+920
| +5% | +$226K | 0.94% | 33 |
|
|
2023
Q3 | $4.98M | Sell |
19,378
-190
| -1% | -$50.8K | 0.94% | 34 |
|
|
2023
Q2 | $5.57M | Sell |
19,568
-124
| -0.6% | -$36.9K | 1.04% | 29 |
|
|
2023
Q1 | $5.47M | Buy |
19,692
+297
| +2% | +$82.2K | 1.11% | 28 |
|
|
2022
Q4 | $5.37M | Sell |
19,395
-802
| -4% | -$227K | 1.18% | 24 |
|
|
2022
Q3 | $5.39M | Sell |
20,197
-280
| -1% | -$59.5K | 1.25% | 20 |
|
|
2022
Q2 | $4.18M | Buy |
20,477
+126
| +0.6% | +$25.8K | 0.91% | 39 |
|
|
2022
Q1 | $4.29M | Buy |
20,351
+855
| +4% | +$186K | 0.8% | 43 |
|
|
2021
Q4 | $4.68M | Buy |
19,496
+643
| +3% | +$165K | 0.85% | 42 |
|
|
2021
Q3 | $5.33M | Sell |
18,853
-675
| -3% | -$221K | 1.03% | 31 |
|
|
2021
Q2 | $6.76M | Buy |
19,528
+464
| +2% | +$141K | 1.3% | 23 |
|
|
2021
Q1 | $5.33M | Buy |
19,064
+791
| +4% | +$213K | 1.1% | 32 |
|
|
2020
Q4 | $4.47M | Buy |
18,273
+5,375
| +42% | +$1.39M | 1% | 37 |
|
|
2020
Q3 | $3.66M | Buy |
12,898
+432
| +3% | +$120K | 0.93% | 39 |
|
|
2020
Q2 | $3.33M | Sell |
12,466
-133
| -1% | -$40K | 0.92% | 40 |
|
|
2020
Q1 | $3.99M | Buy |
12,599
+1,589
| +14% | +$482K | 1.3% | 26 |
|
|
2019
Q4 | $3.27M | Buy |
11,010
+3,019
| +38% | +$838K | 0.84% | 45 |
|
|
2019
Q3 | $1.86M | Buy |
+7,991
| New | +$1.86M | 0.49% | 69 |
|
|
2015
Q1 | – | Sell |
-4
| Closed | -$1K | – | 106 |
|
|
2014
Q4 | $1K | Buy |
+4
| New | +$1.29K | ﹤0.01% | 320 |
|
Other funds holding BIIB
